Watson 372 50 mg (Loxapine 50 mg)
Pill imprint Watson 372 50 mg has been identified as Loxapine succinate 50 mg.
Loxapine is used in the treatment of schizophrenia; agitation and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for Watson 372 50 mg (Loxapine 50 mg)
- 50 mg
- Blue & White
- 19.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
edetate calcium disodium
sodium lauryl sulfate
FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|51079-0903||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about loxapine
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...